Mural Oncology Plc Net Income
| MURADelisted Stock | 2.04 0.00 0.00% |
As of the 10th of February, Mural Oncology secures the Risk Adjusted Performance of (0.03), standard deviation of 0.6522, and Mean Deviation of 0.3799. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mural Oncology Plc, as well as the relationship between them.
Mural Oncology's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mural Oncology's valuation are provided below:Mural Oncology Plc does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Mural |
Search Suggestions
| M | Macys Inc | Company |
| M | MemeCore | Cryptocurrency |
| MBINN | Merchants Bancorp | Company |
| MHD | Blackrock Muniholdings Closed | Fund |
| MJ | Amplify Alternative Harvest | ETF |
| MXY | ARCA Mexico | Index |
| MGCUSD | Micro Gold Futures | Commodity |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Mural Oncology Plc reported net income of (128.51 Million). This is 137.66% lower than that of the Biotechnology sector and 283.47% lower than that of the Health Care industry. The net income for all United States stocks is 122.51% higher than that of the company.
Mural Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mural Oncology's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mural Oncology could also be used in its relative valuation, which is a method of valuing Mural Oncology by comparing valuation metrics of similar companies.Mural Oncology is currently under evaluation in net income category among its peers.
Mural Fundamentals
| Return On Equity | -1.04 | |||
| Return On Asset | -0.49 | |||
| Current Valuation | (19.94 M) | |||
| Shares Outstanding | 17.34 M | |||
| Shares Owned By Insiders | 13.40 % | |||
| Shares Owned By Institutions | 46.57 % | |||
| Number Of Shares Shorted | 417.44 K | |||
| Price To Book | 0.64 X | |||
| EBITDA | (125 M) | |||
| Net Income | (128.51 M) | |||
| Total Debt | 8.02 M | |||
| Book Value Per Share | 3.19 X | |||
| Cash Flow From Operations | (128.54 M) | |||
| Short Ratio | 3.50 X | |||
| Earnings Per Share | (6.93) X | |||
| Target Price | 6.0 | |||
| Number Of Employees | 116 | |||
| Beta | 2.97 | |||
| Market Capitalization | 35.38 M | |||
| Total Asset | 169.39 M | |||
| Retained Earnings | (159.37 M) | |||
| Working Capital | 126.72 M | |||
| Net Asset | 169.39 M |
About Mural Oncology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mural Oncology Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mural Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mural Oncology Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Mural Stock
If you are still planning to invest in Mural Oncology Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mural Oncology's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |